News

UK microbiome therapeutics company CHAIN Biotechnology has appointed two new non-executive directors, Dr Nel Moore and Dr Robert Haigh to the Board.Dr Nel Moore has considerable experience in drug development with a track record taking therapeutics to market as former Global Product Vice President at...

Biogelx today announced the launch and commercial availability of its first synthetic bioink product range.The Biogelx™-INKs have the company’s core self-assembling peptide technology, but have been developed with printability in mind. Like the company’s hydrogel products, Biogelx™-INKs form a nanofibrous network, mimicking the extracellular matrix...

Lamellar Biomedical Limited (Lamellar), an innovative biotechnology company pioneering new approaches for the safe and effective transfer of functional nucleic acids with its LAMELLASOME™ NAT platform, announce the creation of additional capacity through its expansion into the BioCity biotech incubator, Glasgow. The dedicated formulation and...

The worlds of Biology and Artificial Intelligence (AI) change quickly. Right now we are seeing an extraordinary rate of change where biological understanding and AI converge to address the problems of Healthcare in today’s society and there is a new name bursting on to the...

CuanTec are pleased to announce a major new partner to investor portfolio; Sky Ocean Ventures.Sky Ocean Ventures have a specific mission to invest in ideas and businesses who can help solve the oceans plastic crisis.As Jeremy Darroch, Sky’s Group Chief Executive, put it himself “Sky...

Cellomatics BioSciences Limited, a specialised preclinical laboratory CRO, announces the inclusion of NanoEnTek’s JuLI Stage real-time qualitative and quantitative live-cell imaging technology to its repertoire.Cellomatics BioSciences is continually striving to offer added value to all our client discovery projects. We achieve this by constantly reviewing and...